Hemostasis & Tissue Sealing Agents Market - Global Industry Insights and Forecast, 2022 - 2028

Hemostasis & Tissue Sealing Agents Market - Global Industry Insights and Forecast, 2022 - 2028

Report Description
Hemostasis is a natural process that stops blood loss in case of an injury or incision on the body. The process of hemostasis involves three major steps that includes vascular spasm, platelet plug formation, and coagulation. Maintaining hemostasis is one of the crucial step for clinicians working on surgical procedures and trauma management. Thus, commercially available hemostats and tissue sealing agents play an important role in preventing blood loss in cases of uncontrolled bleeding. These hemostats and tissue sealants are available in the market in the form of patches, powders, gels, sponges, and other formulations that are intended to perform the same function of controlling excessive blood flow.
Market Dynamics
Hemostats and tissue sealants are used in a wide range of medical applications that include hernia fixation surgery, orthopedic surgery, spinal injury, trauma or accident wound closure, ophthalmic injuries or replacements, burns, neurosurgeries, urological disorders, and other chronic conditions to control excessive bleeding. Thus, increasing number of surgical procedures is expected to be a major factor augmenting growth of the global hemostasis and tissue sealing agents market. For instance, according to the Wound Management Innovation Center, 2015, wounds are estimated to affect over 433,000 people in Australia and the economic burden is estimated to be around US$ 2.85 billion per year. Moreover, according to The World Bank in 2012, the number of surgical procedures performed per 100,000 population were accounted to be 4,511 globally. However, lack of reimbursement for these agents and products could hinder the market growth.
Key features of the study:
This report provides in-depth analysis of hemostasis & tissue sealing agents market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global hemostasis & tissue sealing agents market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study includes Cryolife, Inc. Baxter International, Inc., Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc., Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global hemostasis & tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the hemostasis & tissue sealing agents market
Detailed Segmentation:
Global Hemostasis & Tissue Sealing Agents Market, By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
Global Hemostasis & Tissue Sealing Agents Market, By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Global Hemostasis & Tissue Sealing Agents Market, By Geography:
North America
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
U.S.
Canada
Latin America
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
Brazil
Mexico
Rest of Latin America
Europe
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Cryolife, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Baxter International, Inc.
Ethicon LLC
Integra Lifesciences Corporation
Becton, Dickinson & Company
Cohera Medical, Inc.
Pfizer, Inc.
Medtronic
B. Braun Melsungen AG
MIL Laboratories Pvt. Ltd
Advanced Medical Solutions Group Plc
“*” marked represents similar segmentation in other categories in the respective section.